Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS ) is a biotechnology company with three commercial products generating sales and proprietary formulation modification technologies. I recommend that investors monitor this company as its revenue is accelerating thanks to the sales ofAnalyst’s Disclosure:I/we have a beneficial long position in the shares of XERS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensat ...